Evidence map›Paper›PMID 24059348›Full record

ArticleStem cells and development2014

Transcriptional reprogramming and chromatin remodeling accompanies Oct4 and Nanog silencing in mouse trophoblast lineage.

Timothy S Carey, Inchul Choi, Catherine A Wilson, Monique Floer, Jason G Knott

Abstract read
In one paragraph

Article in Stem cells and development, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Conserved and divergent features of trophoblast stem cells.Journal of molecular endocrinology · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Epigenesis and plasticity of mouse trophoblast stem cells.Cellular and molecular life sciences : CMLS · 2016
    Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Timothy S Carey1 Developmental Epigenetics Laboratory, Department of Animal Science, Michigan State University , East Lansing, Michigan.
Inchul Choi
Catherine A Wilson
Monique Floer
Jason G Knott
Michigan State University · US

Funding

Role of Brg1 in Embryo Development and PluripotencyR01GM095347 · NIGMS · MICHIGAN STATE UNIVERSITY · PI KNOTT, JASON GLENN · 2010 to 2013
$1.1M
NIGMS NIH HHS GM095347NIGMS NIH HHS R01 GM095347
6 · The paper itself

Abstract

In mouse blastocysts, CDX2 plays a key role in silencing Oct4 and Nanog expression in the trophectoderm (TE) lineage. However, the underlying transcriptional and chromatin-based changes that are associated with CDX2-mediated repression are poorly understood. To address this, a Cdx2-inducible mouse embryonic stem (ES) cell line was utilized as a model system. Induction of Cdx2 expression resulted in a decrease in Oct4/Nanog expression, an increase in TE markers, and differentiation into trophoblast-like stem (TS-like) cells within 48 to 120 h. Consistent with the down-regulation of Oct4 and Nanog transcripts, a time-dependent increase in CDX2 binding and a decrease in RNA polymerase II (RNAPII) and OCT4 binding was observed within 48 h (P<0.05). To test whether transcriptionally active epigenetic marks were erased during differentiation, histone H3K9/14 acetylation and two of its epigenetic modifiers were evaluated. Accordingly, a significant decrease in histone H3K9/14 acetylation and loss of p300 and HDAC1 binding at the Oct4 and Nanog regulatory elements was observed by 48 h. Accompanying these changes, there was a significant increase in total histone H3 and a loss of chromatin accessibility at both the Oct4 and Nanog regulatory elements (P<0.05), indicative of chromatin remodeling. Lastly, DNA methylation analysis revealed that methylation did not occur at Oct4 and Nanog until 96 to 120 h after induction of CDX2. In conclusion, our results show that silencing of Oct4 and Nanog is facilitated by sequential changes in transcription factor binding, histone acetylation, chromatin remodeling, and DNA methylation at core regulatory elements.

Indexed as

Chromatin Assembly and DisassemblyEpigenesis, GeneticAnimalsCDX2 Transcription FactorCell DifferentiationCell LineCell LineageCellular ReprogrammingDNA MethylationE1A-Associated p300 ProteinEmbryonic Stem CellsHistone Deacetylase 1HistonesHomeodomain ProteinsMiceNanog Homeobox ProteinCdx2 protein, mouseCDX2 Transcription FactorE1A-Associated p300 ProteinEp300 protein, mouseHdac1 protein, mouseHistone Deacetylase 1HistonesHomeodomain ProteinsNanog Homeobox ProteinNanog protein, mouseOctamer Transcription Factor-3Pou5f1 protein, mouseRNA Polymerase IITranscription Factors

Identifiers

PMID24059348
PMCPMC3904517
OpenAlexW2331057028

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.